Glutathione derivatives and their dosage forms
    2.
    发明授权
    Glutathione derivatives and their dosage forms 失效
    谷胱甘肽衍生物及其剂型

    公开(公告)号:US06627732B1

    公开(公告)日:2003-09-30

    申请号:US09673449

    申请日:2000-10-16

    IPC分类号: C07K508

    CPC分类号: C07K5/0215 A61K38/00

    摘要: The present invention provides a glutathione derivative having a dramatically enhanced hematopoiesis promoting effect in the living body represented by the formula (I): where A represents H or a C1-C20 acyl group; R1 represents a C1-C26 alkyl group or a C3-C26 alkenyl group; and R2 represents H, a C1-C26 alkyl group or a C3-C26 alkyl group, with the proviso that compounds are excluded in which R1 is a C1-C10 alkyl group or a C3-C10 alkenyl group, and simultaneously R2 is H, a C1-C10 alkyl group or a C3-C10 alkenyl group. The present invention also provides a salt of the glutathione derivative, or a colloidal composition that enables the safe and effective development of the effects of the glutathione derivative in the living body.

    摘要翻译: 本发明提供一种在由式(I)表示的活体中具有显着增强的造血作用促进作用的谷胱甘肽衍生物:其中A表示H或C1-C20酰基; R1表示C1-C26烷基或C3-C26烯基; 并且R 2表示H,C 1 -C 26烷基或C 3 -C 26烷基,条件是排除其中R 1为C 1 -C 10烷基或C 3 -C 10烯基的化合物,同时R2为H, C1-C10烷基或C3-C10烯基。 本发明还提供谷胱甘肽衍生物的盐或能够安全有效地发挥生物体中谷胱甘肽衍生物的作用的胶体组合物。